While increased CCR2 mRNA expression was found in the liver of NASH patients compared to NAFL patients or control subjects [127], liver mRNA expression of its counterligand MCP-1/CCL2 was positively correlated with liver fat content (Table 1) [128,129,130]. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.